NEW YORK (Reuters Health) – Although patients with liver disease often have an increased international normalized ratio (INR), their coagulopathy does not protect against venous thromboembolism (VTE), new…
NEW YORK (Reuters Health) – Genital ulcers are common in HIV-infected women when antiretroviral therapy (ART) begins, particularly when CD4 counts are low or when women have had…
NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor…
NEW YORK (Reuters Health) – The benefits of statins are variable and depend on the agent being taken, a meta-analysis has shown. Pooled data from 10 randomized trials…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
NEW YORK (Reuters Health) – In patients with chronic hepatitis B virus (HBV) infection who are hepatitis B e antigen-positive, viral genotype is one of the strongest predictors…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
NEW YORK (Reuters Health) – While the risk of stroke after a transient ischemic attack (TIA) is highest in the first few days, stroke risk remains elevated even…
NEW YORK (Reuters Health) – Androgen suppression therapy – and its attendant side effects — may not be necessary for patients with intermediate-risk prostate cancer treated with combination…